Myelopeptide-2 (MP-2) with the sequence Leu-Val-Val-Tyr-Pro-Trp is originally isolated from the supernatant of porcine bone marrow cell culture and is able to restore the mitogen responsiveness of human T lymphocytes inhibited by conditioned medium from HL-60 leukemia cells or measles virus.

The MP-2 recovery effect is connected with its influence on the CD3 and CD4 antigen expression on T lymphocytes. Research results also suggest that the MP-2 involvement in regulatory processes is directed to the maintenance of immune homeostasis. This peptide is a perspective to be applied in antitumor and antivirus therapy.

TP2193

C41H57N7O8

775.93

Myelopeptide-2 (MP-2)

DMSO:≥77.5mg/mL
Powder: -20°C for 3 years
In solvent: -80°C for 2 years